December 2015

Cure SMA Funding Leads to 18 New Research Publications in 2015

An important goal of our research funding strategy is to share scientific findings with the broader scientific community. To help accomplish this goal, scientists who receive Cure SMA funding often publish their findings in peer-reviewed journals. Published articles allow the experiments and results to be reviewed and vetted by other scientists, who may then use […]

Cure SMA Funding Leads to 18 New Research Publications in 2015 Read More »

Cure SMA Funds 28 Research Projects in 2015, as Drug Pipeline Grows to 18 Programs

Our approach to research is focused on continually expanding the pipeline of potential drugs and therapies for SMA, cultivating new approaches and advancing promising ideas. Every year, the pipeline gets broader and deeper. We’ve seen enormous growth over the past decade, and we expect that growth to continue in the coming years as more projects

Cure SMA Funds 28 Research Projects in 2015, as Drug Pipeline Grows to 18 Programs Read More »

Cure SMA Reaches Thousands of Families in 2015

Each year, Cure SMA provides thousands of families with vital support and resources to help them live active, engaged and hopeful lives. Our programs provide tangible support for families affected by SMA, easing the difficulties of an SMA diagnosis, and showing each family that they are not alone and that there is hope. Our family

Cure SMA Reaches Thousands of Families in 2015 Read More »

5th Annual Congressional Dinner Brings Together Families, Government and Industry

On December 1, more than 120 people from the SMA community—including government, and industry partners—gathered for the 5th Annual “Hope on the Hill” Congressional Dinner. Several Members of Congress attended the dinner, including Speaker of the House Paul Ryan, Congressman Sean Duffy, Congressman Richard Hudson, Congressman Bill Huizenga, Congressman Erik Paulsen, Congressman David Schweikert, and

5th Annual Congressional Dinner Brings Together Families, Government and Industry Read More »

Cure SMA and Cytokinetics Announce Partnership to Advance Education and Awareness of Spinal Muscular Atrophy

ELK GROVE VILLAGE, Ill. and SOUTH SAN FRANCISCO, Calif., Dec 8, 2015 – Cure SMA and Cytokinetics Inc. (Nasdaq: CYTK), a leading muscle biology company, today announced an expanded partnership to increase education, awareness and fundraising for spinal muscular atrophy (SMA). As a National Gold Partner, Cytokinetics will lend support to key national and local

Cure SMA and Cytokinetics Announce Partnership to Advance Education and Awareness of Spinal Muscular Atrophy Read More »

Cure SMA Scientific Advisory Board Meets in Chicago

Members of Cure SMA’s Scientific Advisory Board (SAB) have gathered in Chicago, meeting to advance Cure SMA’s research goals. Our SAB is made up of highly respected SMA researchers, including experts in child neuromuscular disorders, SMA biology, SMN splicing, motor neurons, mouse and other animal models, and more. The SAB focuses on identifying the most

Cure SMA Scientific Advisory Board Meets in Chicago Read More »

Scroll to Top